Mill Creek Life Sciences receives grant

Mill Creek Life Sciences receives grant from Regenerative Medicine Minnesota to support product testing and development

Written By: 
L.J. Dalrymple

Rochester MN Mill Creek Life Sciences announces receipt of a grant during the inaugural round of funding from Regenerative Medicine Minnesota. Regenerative Medicine Minnesota is a state funded initiative that received 4.35 million dollars in 2015 to stimulate innovation and business related to the growing field of regenerative medicine in the state of Minnesota. The grants are reviewed and administered in a collaboration of the Stem Cell Institute at the University of Minnesota and the Head of Mayo Clinics’ Center of Regenerative Medicine. Mill Creek received a Biotechnology/Biobusiness development grant of $95,600 in this first round of funding. Mill Creek will use the proceeds of the grant to purchase equipment and supplies to support their product testing and product development. “We would like to thank the legislature for their foresight in establishing the availability of these monies, said Al Dietz, CEO of Mill Creek, “This is a rapidly growing field with the potential to significantly impact the economy of Minnesota. Grants to accelerate technology and product development such as these help Mill Creek maintain its competitive edge and this investment will have rapid return both for us and for the state.”

About Mill Creek Life Sciences LLC
Mill Creek LifeSciences LLC is a Rochester based technology company specializing in platelet based media supplements. Mill Creek focuses on supporting new cell therapies for difficult to treat diseases. Mill Creek’s lead product, PLTMax®, (a platelet lysate category of supplementation) is being used in clinical trials to grow stem cells around the world.

Contact Us
To learn more about Mill Creek, please contact: 
Jeff Nielsen, Public Relations
Mill Creek Life Sciences
221 1st Avenue SW Suite 209
Rochester, Minnesota 55902
Phone 507-287-6257
Nielsen.Jeff@millcreekls.com